Skip to main content

Peer Review reports

From: High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer

Original Submission
28 Sep 2023 Submitted Original manuscript
28 Nov 2023 Reviewed Reviewer Report
29 Nov 2023 Reviewed Reviewer Report - Mehmet Baysal
28 Dec 2023 Author responded Author comments - Hiroaki Nagano
Resubmission - Version 2
28 Dec 2023 Submitted Manuscript version 2
4 Jan 2024 Author responded Author comments - Hiroaki Nagano
Resubmission - Version 3
4 Jan 2024 Submitted Manuscript version 3
4 Jan 2024 Author responded Author comments - Hiroaki Nagano
Resubmission - Version 4
4 Jan 2024 Submitted Manuscript version 4
23 Jan 2024 Reviewed Reviewer Report - Mehmet Baysal
24 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
26 Jan 2024 Editorially accepted
2 Feb 2024 Article published 10.1186/s12885-024-11924-4

You can find further information about peer review here.

Back to article page